CD47 Is Necessary for Inhibition of Nitric Oxide-stimulated Vascular Cell Responses by Thrombospondin-1*
暂无分享,去创建一个
D. Wink | L. Ridnour | D. Roberts | J. Isenberg | W. Frazier | J. Dimitry
[1] K. Ha,et al. Prostaglandin E2 stimulates angiogenesis by activating the nitric oxide/cGMP pathway in human umbilical vein endothelial cells , 2005, Experimental & Molecular Medicine.
[2] J. Keck,et al. Structure of the calcium-rich signature domain of human thrombospondin-2 , 2005, Nature Structural &Molecular Biology.
[3] D. Wink,et al. Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[4] D. Wink,et al. Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[5] J. Lawler,et al. Endogenous thrombospondin-1 is not necessary for proliferation but is permissive for vascular smooth muscle cell responses to platelet-derived growth factor. , 2005, Matrix biology : journal of the International Society for Matrix Biology.
[6] D. Ingber,et al. Inhibition of endothelial cell migration by thrombospondin-1 type-1 repeats is mediated by β1 integrins , 2005, The Journal of cell biology.
[7] B. Banas,et al. Identification of Novel β1 Integrin Binding Sites in the Type 1 and Type 2 Repeats of Thrombospondin-1* , 2004, Journal of Biological Chemistry.
[8] J. Murphy-Ullrich,et al. The N-terminus of thrombospondin: the domain stands apart. , 2004, The international journal of biochemistry & cell biology.
[9] Josephine C. Adams,et al. Coronary artery disease and the thrombospondin single nucleotide polymorphisms. , 2004, The international journal of biochemistry & cell biology.
[10] M. Detmar,et al. Tumor progression: the effects of thrombospondin-1 and -2. , 2004, The international journal of biochemistry & cell biology.
[11] A. Zheleznyak,et al. Cholesterol-independent Interactions with CD47 Enhance αvβ3 Avidity* , 2004, Journal of Biological Chemistry.
[12] Josephine C. Adams,et al. Structure of a thrombospondin C‐terminal fragment reveals a novel calcium core in the type 3 repeats , 2004, The EMBO journal.
[13] David D Roberts,et al. &agr;4&bgr;1 Integrin Mediates Selective Endothelial Cell Responses to Thrombospondins 1 and 2 In Vitro and Modulates Angiogenesis In Vivo , 2004, Circulation research.
[14] Tokichi Miyakawa,et al. Ultraviolet B-induced skin angiogenesis is associated with a switch in the balance of vascular endothelial growth factor and thrombospondin-1 expression. , 2004, The Journal of investigative dermatology.
[15] J. Cooke. NO and angiogenesis. , 2003, Atherosclerosis. Supplements.
[16] C. Sorenson,et al. Thrombospondin‐1–deficient mice exhibit increased vascular density during retinal vascular development and are less sensitive to hyperoxia‐mediated vessel obliteration , 2003, Developmental dynamics : an official publication of the American Association of Anatomists.
[17] J. Heuser,et al. Endocytosis of Oxidized Low Density Lipoprotein through Scavenger Receptor CD36 Utilizes a Lipid Raft Pathway That Does Not Require Caveolin-1* , 2003, Journal of Biological Chemistry.
[18] R. Kerbel,et al. Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[19] W. Frazier,et al. An amyloid-like C-terminal domain of thrombospondin-1 displays CD47 agonist activity requiring both VVM motifs. , 2003, Biochemistry.
[20] Douglas R. McDonald,et al. A Cell Surface Receptor Complex for Fibrillar β-Amyloid Mediates Microglial Activation , 2003, The Journal of Neuroscience.
[21] K. Moore,et al. A CD36-initiated Signaling Cascade Mediates Inflammatory Effects of β-Amyloid* , 2002, The Journal of Biological Chemistry.
[22] H. Krutzsch,et al. Regulation of Integrin Function by CD47 Ligands , 2002, The Journal of Biological Chemistry.
[23] A. Joachimiak,et al. Crystal structure of the TSP-1 type 1 repeats , 2002, The Journal of cell biology.
[24] J. Lawler,et al. The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in double-TSP1/TSP2-null mice. , 2002, The American journal of pathology.
[25] H. Krutzsch,et al. Interactions of thrombospondins with α4β1 integrin and CD47 differentially modulate T cell behavior , 2002, The Journal of cell biology.
[26] R. Hynes,et al. Thrombospondin-1 gene expression affects survival and tumor spectrum of p53-deficient mice. , 2001, The American journal of pathology.
[27] R K Jain,et al. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[28] C. Legrand,et al. A Model of Platelet Aggregation Involving Multiple Interactions of Thrombospondin-1, Fibrinogen, and GPIIbIIIa Receptor* , 2001, The Journal of Biological Chemistry.
[29] D. Roberts,et al. Thrombospondin-1 Inhibits TCR-Mediated T Lymphocyte Early Activation , 2001, The Journal of Immunology.
[30] Mark L. Benson,et al. Isolation of vascular smooth muscle cells from a single murine aorta. , 2001, Methods in cell science : an official journal of the Society for In Vitro Biology.
[31] D. Mosher,et al. Physical Characterization of the Procollagen Module of Human Thrombospondin 1 Expressed in Insect Cells* , 2000, The Journal of Biological Chemistry.
[32] M. Iruela-Arispe,et al. Cell Contact–dependent Activation of α3β1 Integrin Modulates Endothelial Cell Responses to Thrombospondin-1 , 2000 .
[33] A. Zeiher,et al. Phosphorylation of the endothelial nitric oxide synthase at Ser‐1177 is required for VEGF‐induced endothelial cell migration , 2000, FEBS letters.
[34] O. Volpert,et al. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1 , 2000, Nature Medicine.
[35] T. Shono,et al. Role of thrombospondin-1-derived peptide, 4N1K, in FGF-2-induced angiogenesis. , 1999, Experimental cell research.
[36] F. Lindberg,et al. Integrin-Associated Protein Stimulates α2β1-Dependent Chemotaxis via GI-Mediated Inhibition of Adenylate Cyclase and Extracellular-Regulated Kinases , 1999, The Journal of cell biology.
[37] K. Gardner,et al. Beta 1 integrin- and proteoglycan-mediated stimulation of T lymphoma cell adhesion and mitogen-activated protein kinase signaling by thrombospondin-1 and thrombospondin-1 peptides. , 1999, Journal of immunology.
[38] M. Iruela-Arispe,et al. Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats. , 1999, Circulation.
[39] J. Isner,et al. Antibody blockade of thrombospondin accelerates reendothelialization and reduces neointima formation in balloon-injured rat carotid artery. , 1999, Circulation.
[40] Yukitaka Shizukuda,et al. Vascular Endothelial Growth Factor–Induced Endothelial Cell Migration and Proliferation Depend on a Nitric Oxide–Mediated Decrease in Protein Kinase Cδ Activity , 1999 .
[41] E. Brown,et al. The Thrombospondin Receptor Integrin-associated Protein (CD47) Functionally Couples to Heterotrimeric Gi * , 1999, The Journal of Biological Chemistry.
[42] O. Volpert,et al. Three distinct D-amino acid substitutions confer potent antiangiogenic activity on an inactive peptide derived from a thrombospondin-1 type 1 repeat. , 1999, Molecular pharmacology.
[43] J. Lawler,et al. CD36 mediates binding of soluble thrombospondin‐1 but not cell adhesion and haptotaxis on immobilized thrombospondin‐1 , 1998, Cell biochemistry and function.
[44] R. Hynes,et al. Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. , 1998, The Journal of clinical investigation.
[45] R. Silverstein,et al. Lysosomal Integral Membrane Protein II Binds Thrombospondin-1 , 1998, The Journal of Biological Chemistry.
[46] J. Isner,et al. Immunolocalization of thrombospondin-1 in human atherosclerotic and restenotic arteries. , 1998, American heart journal.
[47] G. Garcı́a-Cardeña,et al. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. , 1997, The Journal of clinical investigation.
[48] David W. Dawson,et al. CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells , 1997, The Journal of cell biology.
[49] R Bicknell,et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. , 1997, The Journal of clinical investigation.
[50] Eric J. Brown,et al. Decreased Resistance to Bacterial Infection and Granulocyte Defects in IAP-Deficient Mice , 1996, Science.
[51] E. Brown,et al. Thrombospondin modulates alpha v beta 3 function through integrin- associated protein , 1996, The Journal of cell biology.
[52] E. Brown,et al. Integrin-associated Protein Is a Receptor for the C-terminal Domain of Thrombospondin (*) , 1996, The Journal of Biological Chemistry.
[53] S. Mousa,et al. Thrombospondin Mediates Calcium Mobilization in Fibroblasts via Its Arg-Gly-Asp and Carboxyl-terminal Domains (*) , 1995, The Journal of Biological Chemistry.
[54] D. Roberts,et al. Purification of thrombospondin from human platelets , 1994 .
[55] H. Krutzsch,et al. Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin‐binding domain and synthetic peptides from the type I repeats of thrombospondin , 1993, Journal of cellular biochemistry.
[56] P. Hogg,et al. Modulation of Fibrinolysis by Thrombospondin a , 1992, Annals of the New York Academy of Sciences.